|
|
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy
,
Emmanuelle Le Chatelier
,
Lisa Derosa
,
Connie Duong
,
Maryam Tidjani Alou
et al.
Journal articles
hal-02126484v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort
Solenn Brosseau
,
Claire Danel
,
Arnaud Scherpereel
,
Julien Mazières
,
Sylvie Lantuejoul
et al.
Journal articles
hal-02511543v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study
Pierre Mordant
,
Solenn Brosseau
,
Bernard Milleron
,
Nicola Santelmo
,
Séverine Fraboulet-Moreau
et al.
Journal articles
hal-03800571v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial
Elodie Maille
,
Solenn Brosseau
,
Vincent Hanoux
,
Christian Creveuil
,
Claire Danel
et al.
Journal articles
hal-02103278v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells
Maureen Keller
,
Fatéméh Dubois
,
Sylvain Teulier
,
Alexandre Martin
,
Jérôme Levallet
et al.
Journal articles
hal-02086738v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
Guillaume Manson
,
Alexandre Thibault Jacques Maria
,
Florence Poizeau
,
François-Xavier Danlos
,
Marie Kostine
et al.
Journal articles
hal-02530293v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience
Jean Philippe Spano
,
Marianne Veyri
,
Aurélien Gobert
,
Amelie Guihot
,
Philippe Perré
et al.
Journal articles
hal-02591390v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice
Pascale Tomasini
,
Solenn Brosseau
,
Julien Mazières
,
Jean Merlio
,
Michèle Beau-Faller
et al.
Journal articles
hal-01699297v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
Marine Baron
,
Cathia Soulié
,
Armelle Lavolé
,
Lambert Assoumou
,
Baptiste Abbar
et al.
Journal articles
hal-03633068v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial
Armelle Lavole
,
Julien Mazieres
,
Sophie Schneider
,
Solenn Brosseau
,
Lize Kiakouama
et al.
Journal articles
hal-03524445v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|